$RLFTF Martins Math from Ya-h00 : I see the ol' S
Post# of 653
As a purely hypothetical , contrived ,simplistic and ambitious scenario , consider this :
For IV U.S./Canada/Israel only 1,000,000 3-course treatments at $9,000 per =
$9Billion Gross sales X .25 for RT NET = $2.25B X avg pharma P/E of 20 (actually 23)=
$45 Billion Market Cap divided by 3.5 billion shares = ~$13 SP , for U.S. IV only .
I am guessing that the SP will RISE well above that with approval announcements !
But it all starts with EUA , coming sooner rather than later !